AFT Forsyth & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,518
| Closed | -$225K | – | 129 |
|
|
2023
Q2 | $225K | Buy |
3,518
+101
| +3% | +$6.46K | 0.16% | 124 |
|
|
2023
Q1 | $237K | Sell |
3,417
-229
| -6% | -$15.9K | 0.18% | 122 |
|
|
2022
Q4 | $262K | Sell |
3,646
-80
| -2% | -$5.76K | 0.22% | 115 |
|
|
2022
Q3 | $265K | Buy |
3,726
+1
| +0% | +$71 | 0.24% | 113 |
|
|
2022
Q2 | $287K | Hold |
3,725
| – | – | 0.23% | 109 |
|
|
2022
Q1 | $272K | Buy |
3,725
+1
| +0% | +$73 | 0.17% | 127 |
|
|
2021
Q4 | $232K | Sell |
3,724
-499
| -12% | -$31.1K | 0.12% | 143 |
|
|
2021
Q3 | $250K | Hold |
4,223
| – | – | 0.13% | 138 |
|
|
2021
Q2 | $282K | Buy |
4,223
+1
| +0% | +$67 | 0.15% | 136 |
|
|
2021
Q1 | $267K | Sell |
4,222
-148
| -3% | -$9.36K | 0.16% | 131 |
|
|
2020
Q4 | $271K | Sell |
4,370
-71
| -2% | -$4.4K | 0.17% | 129 |
|
|
2020
Q3 | $268K | Buy |
4,441
+618
| +16% | +$37.3K | 0.2% | 115 |
|
|
2020
Q2 | $225K | Buy |
+3,823
| New | +$225K | 0.19% | 116 |
|
|
2020
Q1 | – | Sell |
-3,208
| Closed | -$206K | – | 126 |
|
|
2019
Q4 | $206K | Buy |
+3,208
| New | +$206K | 0.16% | 135 |
|
|
2018
Q4 | – | Sell |
-3,440
| Closed | -$214K | – | 137 |
|
|
2018
Q3 | $214K | Buy |
+3,440
| New | +$214K | 0.18% | 133 |
|
|
2018
Q2 | – | Sell |
-3,525
| Closed | -$223K | – | 140 |
|
|
2018
Q1 | $223K | Sell |
3,525
-2,425
| -41% | -$153K | 0.21% | 127 |
|
|
2017
Q4 | $365K | Buy |
+5,950
| New | +$365K | 0.36% | 97 |
|
|
2013
Q3 | $717K | Buy |
15,494
+700
| +5% | +$32.4K | 0.93% | 31 |
|
|
2013
Q2 | $661K | Buy |
+14,794
| New | +$661K | 0.94% | 34 |
|